EGFR tyrosine kinase inhibitors (Beijing University of Technology/Guangzhou Institute of Biomedicine and Health/Beijing Dalitai Pharmaceutical Technology)
N/A
Report date: 2026/05/09 20:00:18
NME
Base Information
Drug NameEGFR tyrosine kinase inhibitors (Beijing University of Technology/Guangzhou Institute of Biomedicine and Health/Beijing Dalitai Pharmaceutical Technology)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing University Of Technology
China Registration ClassN/A
Develop Information
Active CompaniesBeijing University Of TechnologyBeijing Dalitai Pharmaceutical Technology Co. LtdGuangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A